https://www.selleckchem.com/products/GDC-0449.html 
  We previously identified estrogen-responsive finger protein (Efp) as an estrogen-induced gene, and showed that the positive immunoreactivity of Efp is a poor prognostic factor for patients with breast cancer. We also demonstrated that Efp has distinctive roles in innate immunity by activating pattern recognition receptor retinoic acid-inducible gene I (RIG-I). The clinical value of RIG-I protein expression in breast cancer had not been evaluated in relationship with patients' prognosis. Tissue samples of estrogen receptor-positive inva
 
					 
						 
                    
                                     
       
       
       
       
       
       
       
       
       
         